Intrinsic Value of S&P & Nasdaq Contact Us

Nyxoah S.A. NYXH NASDAQ

NASDAQ Global Market • Healthcare • Medical - Instruments & Supplies • BE • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+205.8%

Stock Statistics — NYXH

Nyxoah S.A. (NYXH) has a market capitalization of $122.12M and trades at $3.27. The 52-week range is 2.76-8.64.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-2.37, annual revenue of $10.02M.

The stock has a beta of 0.87, operates in the Healthcare sector.

Trading Data
Current Price$3.27
52-Week Range2.76-8.64
Volume77.42K
Avg Volume (30D)56.13K
Market Cap$122.12M
Beta (1Y)0.87
Company
IPO Date2021-04-28
Employees183
CEOOlivier Taelman
CountryBE
ExchangeNASDAQ Global Market
CurrencyUSD
ISINBE0974358906
Income (Latest Year)
Revenue$10.02M
Gross Profit$6.32M
EBITDA$-84.73M
Operating Income$-84.73M
Net Income$-90.05M
EPS$-2.37
EPS Diluted$-2.37
Shares Outstanding$38.11M
Balance Sheet (Latest Year)
Total Assets$118.43M
Current Assets$61.19M
Cash & ST Investments$47.98M
Total Liabilities$69.34M
Total Debt$42.06M
Net Debt$12.07M
Total Equity$49.11M
Debt / Equity0.86
Valuation Ratios
P/E Ratio-1.4
P/S Ratio12.19
P/B Ratio2.49
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message